GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgical Innovations Group PLC (LSE:SUN) » Definitions » EV-to-EBITDA

Surgical Innovations Group (LSE:SUN) EV-to-EBITDA : 31.76 (As of Jun. 09, 2024)


View and export this data going back to 1988. Start your Free Trial

What is Surgical Innovations Group EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Surgical Innovations Group's enterprise value is £5.11 Mil. Surgical Innovations Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was £0.16 Mil. Therefore, Surgical Innovations Group's EV-to-EBITDA for today is 31.76.

The historical rank and industry rank for Surgical Innovations Group's EV-to-EBITDA or its related term are showing as below:

LSE:SUN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -30.39   Med: 11.79   Max: 85.85
Current: 31.76

During the past 13 years, the highest EV-to-EBITDA of Surgical Innovations Group was 85.85. The lowest was -30.39. And the median was 11.79.

LSE:SUN's EV-to-EBITDA is ranked worse than
80.17% of 479 companies
in the Medical Devices & Instruments industry
Industry Median: 15.48 vs LSE:SUN: 31.76

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-09), Surgical Innovations Group's stock price is £0.005. Surgical Innovations Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.001. Therefore, Surgical Innovations Group's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Surgical Innovations Group EV-to-EBITDA Historical Data

The historical data trend for Surgical Innovations Group's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgical Innovations Group EV-to-EBITDA Chart

Surgical Innovations Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.62 -15.14 85.28 23.71 37.56

Surgical Innovations Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 85.28 - 23.71 - 37.56

Competitive Comparison of Surgical Innovations Group's EV-to-EBITDA

For the Medical Devices subindustry, Surgical Innovations Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgical Innovations Group's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Surgical Innovations Group's EV-to-EBITDA falls into.



Surgical Innovations Group EV-to-EBITDA Calculation

Surgical Innovations Group's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=5.114/0.161
=31.76

Surgical Innovations Group's current Enterprise Value is £5.11 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Surgical Innovations Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was £0.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Surgical Innovations Group  (LSE:SUN) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Surgical Innovations Group's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.005/-0.001
=At Loss

Surgical Innovations Group's share price for today is £0.005.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Surgical Innovations Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.001.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Surgical Innovations Group EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Surgical Innovations Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Surgical Innovations Group (LSE:SUN) Business Description

Traded in Other Exchanges
N/A
Address
Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and precision engineering markets. The group sells branded products through independent healthcare distributors across the world and own-label products through original equipment manufacturer relationships. The SI Brand segment includes research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The distribution segment includes the distribution of specialist medical products.